|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
2/20/2013 7:43:55 AM
Just as Express Scripts began digesting its $29 billion acquistion of Medco Health Solutions, one of its consultants allegedly began trolling for trade secrets to build its own healthcare business, according to a lawsuit filed by the pharmacy benefits manager. The culprit? Ernst & Young and one of its partners, which were “possessed with an evil motive and their conduct shocks the conscious,” the lawsuit states. In its lawsuit, which was filed in a Missouri state court, Express Scripts charges that Ernst & Young partner Don Gravlin was “sneaking” into its headquarters and stealing confidential information over a number of months. Specifically, the pharmacy benefits claims the equivalent of 20,000 pages of data that included information on pricing, integration strategy and business strategy, among other things, was emailed to a private Google account. Ernst & Young “stole… proprietary and confidential information to grow and develop additional business in its health care segment, including potential additional business with Express Scripts (ESRX), Medco and their direct competitors,” the lawsuit states. Express Scripts discovered the alleged theft last August and claims an Ernst & Young partner in charge of the account was aware that Gavlin, who is no longer with the firm, had taken data but did not notify Express Scripts. Of course, allegations of stealing trade secrets are nothing new and companies regularly monitor consultants and their online activities over such concerns, as happened in this instance. In any event, Express Scripts is a fat target – after purchasing Medco, the pharmacy benefit manager now oversees benefits for more than 115 million people, dispenses one third of all prescriptions filled in the US and controls 60 percent of the mail-order drug market.
|
|
|
|
|
|
|
|
|
|
|